Início › Miastenia Gravis › Texas
Ensaios clínicos de Miastenia Gravis em Texas
18 estudos para Miastenia Gravis estão buscando participantes em locais em Texas.
Cidades em Texas
Texto oficial do estudo (Inglês)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Austin Neuromuscular Center, Austin
- Texas Neurology, Dallas
RecrutandoFase 3
Idades de 18 a 74 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Houston
RecrutandoFase 3
Idades de 18 a 80 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07647510ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07673627ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07284420Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Baylor Scott & White Research Institute - Baylor Scott & White Research Institute, Dallas
- ANESC Research, El Paso
- Baylor Scott & White Neurology - McKinney, McKinney
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06463587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- Nerve and Muscle Center of Texas - Neurology, Houston
- Texas Institute for Neurological Disorders, Sherman
- Neurology Care Clinic, Waxahachie
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07501702A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Austin Neuromuscular Center, Austin
RecrutandoFase 2
Idades de 2 a 17 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06987539RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Baylor College of Medicine Neurology Department, Houston
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades de 18 a 70 · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT06359041Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Houston
RecrutandoFase 1/2
Idades de 18 a 85 · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT07596901Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1003, Dallas
- Site Number - 1047, Denton
- Site Number - 1057, Houston
- e mais 1
RecrutandoFase 3
Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Houston Methodist Hospital, Houston
RecrutandoFase 2/3
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT06193889A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of Texas Southwestern Medical Center, Dallas
- Houston Methodist Neurological Institute, Houston
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- UT Southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de fev. de 2026 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 18 de fev. de 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- National Neuromuscular Research Institute, Austin
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 17 de fev. de 2026 · NCT06298565A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- Nerve & Muscle Center of Texas, Houston
- Houston Methodist Neurological Institute, Houston
RecrutandoFase 1/2
Idades de 18 a 74 · Todos os sexos · Atualizado em 11 de fev. de 2026 · NCT07250750Vitaccess Real MG Registry
- University of Texas Health Science Center at Houston, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2025 · NCT06064461Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.